Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance
Go back to Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance| (NASDAQ: AUTL) | Delayed: 2.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.22 | 52 Week High | $ | |||
| Open | $2.22 | 52 Week Low | $ | |||
| Day High | $2.22 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 4,740 | |||||

